ENDPOINTS

Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves

William Pao, a longtime R&D leader at Roche who briefly held the chief development officer post at Pfizer until the summer of 2023, has been stealthily leading a biotech ...

Feb 28, 2025 - 13:03
 0
Pfizer vet William Pao’s next venture; Sanofi’s computational science exec leaves
William Pao, a longtime R&D leader at Roche who briefly held the chief development officer post at Pfizer until the summer of 2023, has been stealthily leading a biotech ...
Read More

Tags:

Previous Article

There’s finally a gadget that helps me crack open a cold one and charge my phone

Next Article

Trump’s science crackdown hits rare disease medicine: ‘We need to sit down with ...

Related Posts

Odyssey underwent layoffs; GSK to move vaccine R&D site to Cambridge

Odyssey underwent layoffs; GSK to move vaccine R&D site...

Feb 12, 2025  0

NIH payment cuts are 'reasoned and rational,' government says

NIH payment cuts are 'reasoned and rational,' governmen...

Feb 18, 2025  0

Arcus touts early kidney cancer data as Gilead declines option

Arcus touts early kidney cancer data as Gilead declines...

Feb 18, 2025  0